FBLG
FBLG
NASDAQ · Biotechnology

Fibrobiologics Inc

$0.20
-0.02 (-10.64%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +10,195.0% upside
Low Target $14.74
Average Target $20.24
High Target $23.30
Current Price $0.20
Current
$0.20
Target
$20.24
$14.74 $20.24 avg $23.30
Scenario Analysis
Bear Case
$14.74
7,397.5%
Low target
Base Case
$20.24
+10,195.0%
Avg target
Bull Case
$23.30
+11,751.5%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$1.53
-87.2% from high
52-Week Low
$0.19
+6.2% from low
Target vs 52W High
$20.24
+1,222.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.9%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +157.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.5%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.0%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.5%